相关实验视频

Updated: Jun 17, 2025

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

通过促进免疫细胞死亡,p53-武装的性病毒疗法在骨髓瘤中诱导了abscopal效应

Koji Demiya¹, Hiroshi Tazawa^2,3, Hiroya Kondo¹

¹Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Molecular therapy. Oncology

|August 7, 2024

概括

在骨髓瘤 (OS) 细胞中,p53-armed oncolytic adenovirus OBP-702有效诱导免疫细胞死亡 (ICD),从而触发骨髓瘤效应. 这表明OBP-702是通过增强抗瘤免疫力来治疗OS的有希望的试剂.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
病毒学病毒学

背景情况:

骨髓瘤 (OS) 是儿童和青少年的一种主要骨癌,由于免疫反应较弱,通常对免疫疗法有抗性.
化疗和病毒疗法可以触发免疫细胞死亡 (ICD),导致未经治疗的瘤中的abscopal效应.

研究的目的:

评估化疗药物和端粒酶特异性瘤性腺病毒 (OBP-301,OBP-702) 在骨髓瘤细胞中诱导ICD的潜力.
为了比较OBP-702与化疗和OBP-301在诱导ICD和抗瘤免疫反应方面的疗效.

主要方法:

人类 (U2OS,MNNG/HOS,SaOS-2) 和小鼠 (NHOS) 骨髓瘤细胞用多克索鲁比,西斯,OBP-301和OBP-702进行治疗.
通过测量腺三酸盐 (ATP) 和高流动性组盒蛋白B1 (HMGB1) 的分泌来评估免疫细胞死亡 (ICD).
在皮下NHOS瘤模型中评估治疗疗效,评估CD8+T细胞透和abscopal效应.

主要成果:

与化疗和OBP-301相比,OBP-702诱导了更强大的ICD,由更高的ATP和HMGB1分泌物证明,与人类OS细胞中的化疗和OBP-301相比.
小鼠NHOS细胞对OBP-702的敏感性比对OBP-301的敏感性更大.
在小鼠体内注射OBP-702显著增加了细胞毒性CD8+T细胞的透,并显示出对未经治疗的瘤的abscopal效应.

结论:

OBP-702作为骨髓瘤的抗瘤剂具有显著的潜力.
OBP-702通过ATP和HMGB1的分泌有效诱导ICD,促进一个abscopal效应.
这些发现支持OBP-702作为骨髓瘤免疫治疗的有希望的候选者.

关键词:

这就是ATPATPATPATP.CCL5 CCL5 CCL5 CCL5 CCL5 CCL5 CCL5 CCL5 CCL5 CCL5 CCL5 CCL5 在CXCL10中,CXCL10是CXCL10中的一个.这就是HMGB1的特点.MT:常规问题这是一种abscopal效应.腺病毒的病毒.免疫性细胞死亡免疫性细胞死亡性病毒疗法性病毒疗法性病毒疗法骨质肉瘤是骨质肉瘤的一种疾病.在p53中,p53是什么?

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...